Skip to main
  1. Stocks
  2. Hinge Health Inc
  3. Forecast
HNGE

HNGE Stock Forecast & Price Target

HNGE Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 33%
Buy 60%
Hold 7%
Sell 0%
Strong Sell 0%

Bulls say

Hinge Health is supported by accelerating demand, with 3Q26 downloads up 59% y/y, September downloads up 100% y/y, and retention metrics still strong as active-user engagement improved even with only modest MAU softness. Its fundamentals also appear durable because management cited win-rates above 80%, 97% retention, $960-970 million of 2026 calculated billings, and strong pipeline visibility from enterprise and SMB selling season, while SensorTower data shows it extending a major lead over Sword. Looking ahead, the business has multiple growth levers in higher-yield cohorts, Hinge Select, surgery, and migraine, and the outlook implies 2027 organic revenue growth of 33% with meaningful margin expansion from a scalable, high-visibility platform.

Bears say

Hinge Health is exposed to significant execution risk because its growth depends on attracting new clients, retaining existing ones on favorable terms, and meeting performance guarantees, any of which could materially hurt revenue, operations, and financial condition. Its reliance on a limited number of health plans and other partners, combined with meaningful upfront relationship costs, raises the risk that weak renewals or slow expansion will prevent recovery of invested capital. The company also faces competitive and product risk if it cannot continuously enhance its AI-powered MSK platform, maintain market acceptance, and deliver high-quality implementation and support in a shifting healthcare and regulatory landscape.

HNGE has been analyzed by 15 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 60% recommend Buy, 7% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Hinge Health Inc and is not a guaranteed prediction by Public.com or investment advice.

HNGE Analyst Forecast & Price Prediction

Get the latest HNGE stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in HNGE

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Hinge Health Inc (HNGE) Forecast

Analysts have given HNGE a Buy based on their latest research and market trends.

According to 15 analysts, HNGE has a Buy consensus rating as of Oct 29, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $101.93, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $101.93, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Hinge Health Inc (HNGE)


HNGE Analyst Forecast & Price Prediction

Get the latest HNGE stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in HNGE

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover HNGE stock data and trends